Axis Vaccine Policy Causes Culture Crisis
While Axis and its employees pride themselves on Axis' culture (see our 2021 report), this is facing a crisis over increasing pressure over non-vaccinated employees in the last year.
Though we first reported about the Axis vaccine requirement earlier this week, new information, from discussions with those close to Axis, show that this conflict grew throughout 2021 and that numerous employees are impacted.
In this note, we examine how restrictions increased and how many potential employees are impacted.
** ***** ** **** ******, **** Americas ****** *** ************ ********* **** having "******** ***********" ******* ** **** offices, ** *** ***** ***** *****:
**** *** * ***** ********* ****** as **** **** ******** ********* **** in ***** ***** ***** (***, **, etc.). ** **** ****** ***** ***** customers, ** ************* ********** *** *********' ability ** ** ***** ****.
********, *** ****** *** *** ********** of ******* ********* *** *** ****** requiring ******** ** ** ********** ** even ** *** ********* **** ************ themselves. **** *****, **** */*** ** those ** ***** *** *** *** vaccinated ** *** ** *** **** than */*** ** ***** **-** *** unvaccinated,*** *** **** ******.
**** *****, **** **** ** ***** to ***+ ********* *** *** *** yet ******** ***** "complete vaccine record" telling them they "cannot travel" (including Axis annual kickoff) and that management thinks this is "best to protect" the unvaccinated, as the email excerpt below shows:
Axis ********
**** ********* ** **** ***** *** ban ** ************ ********* ******** *********:
** ***** ** *** **** ** caution *** *** **** ** *** staff, ******** *** ********* ** ********** that *** ****** ********* *** ******** customers *** ****** **** **********. ************, we **** **** ******** ******* **** of *** *********, ******** *** ****** had *** **** ***********, *** ** was *** **** *** ** ******** the ****-******** ***** *** *********** ***** often ****** ** ******** *** ********.
**** **** **** **** **** ***** 10 ********* *** ********:
******* *** ****** *** ******** **** together ** ** *** ***** ** Axis *******. ** ***** ******* *** employee’s ******** ** *** ** **********. We ******* *********** *** ****** ********* whose ********* ********* ******* ************* ** customer *** ******* ***********, ******** ******, and ******** ******. ** ******** ** encourage *** ************* ** ** *** employees ******** ** **** ****** ** consider **** ********* ****** **** **** do *** ******* ***********.
** **** ***** **** * ****** of **** ********* **** ***/** *** going ** ****** **** **** *** we *** *** ******* ** *** total ******. ** **** *** ****** how **** **** ********* **** *** vaccine ***** ****** ** ***** ***** or *** **** ********* **** ******** from *** ******* ***********.
*** ***** ** *******,** **** *********, *** *** **** ******** ***** will ** ******** ** ** **********.
Culture ********
**** *** ****** *********** ******** ******* Axis *********, ****** ********* *** ********* to ***** ********, ***** **** ***** jobs *** ********* ** ***** ****.
*** ****** **** ********, *** **** 14 ****** ***,******* *. ***************** ********** ********** **** ************ ** "**********" ********* *** **** his ****** **-******* *** "***** ****** to **** ************** *********":
******* ****** ***** ** *** ********* described **** ** * ********** ******* those ** **** ********** ** ************* and **** ********* ********** *** ***, many *** *** ********** *** **** of ****** ***** ****:
********** ** ********** ******** *** *********** about *** ********, ***** ** **** definitely * ********** ******************'* ********** ** ********** *** **** of *** **** ** *** ********. There *** **** * *** ** angst **** ** ***-**** ******* ********* the ********. **** ****** ******* *** got *** *** ** ***** ** maintain ***** ****** ******- *** ** **** ********.
******* **** ****** **** ******* ** the ********** ** ******* *** **** Axis *** *** ***** ** ** its ****** *** *******:
******** ****** *** ******** ***, ****** as ***, *** ****** ****. *** can *** **** ****** ** **** story ** *** *** ***, *** by ******** *** ******** *** ******** classes ************** *********, **** **** *****'* ***** like ****** ** ***.
*** **** ***** ************, "*******" *** "values" *** ****** **** *** **** to ***** ** *** ******* ** profit. *** *** *****, ************ **** *************, **** **** **** really ******** ** ******** ********** ****** **** *******, ***** ***** the ********** **** *** **** ******* policy **** **** *********.
******
**** ******* ************ ********** ************* ****** ************* ****** ******** *** Axis **** *** **** ****-****. *** vaccine ***** ** *********** **** ******* and ******* **** ** **** *** many ** ** ***** ** ***** policies. ****, *** ********** ******* ********* (delays ** * ****** ** **** are ******** ********) **** ******* *** type ** ****** *** **** **** the ******* *** ******** ***** ***** before.
**** **** **** ******* ******* ******* for ****. **** ***** ** **** Tony ***** ** *** ********** ****** their **********.
** **** ** ***** **** ******** and *** ******* ***** ******* **** cameras ********.
**** **** ******* ******* ******* *** them
*** **** **** * ******* ******* America *** **** ********, ***** *** evidently ** ** **** ******...
* ***** ******* ****'* *** **** thing ****'* ***** ** ** ** short ****** *** **** ;*
(*'** *** ****** ***)
************** *********? ** *** *** **** jealous ** ** ****** ** *** Church *** *** **** *****?
**** **** ****** *********?
*** ********* ** ***. **'* **** dumb.
*** ***** ***** ** ** ******* made * ******* ******* ***** ***-******, Ken's *** *****'* ***** ************ ******* how ********* ** ** ** **** about ****** *****.
*** ****** ** *** **** ***** sounds **** ********* ******** *** ** the ******* ******** ****.
**** *** ******** ** ***** **** earlier **** ***** ** ***** **** provided ********* ***** ******* ********* ***********, including **** ***-********** ********* ******:
**** ****** ****** **** *** ***** for ************, *** **** ***** ** find ** ********* ******** *** ************ employees.
** ***** ** **** ** *** those ****** ******* ********* *********. * know * *** ****** ****** **** who **** *******, **** *** ******* me ****'** **** ** **** ******.
** ******* **** *** ** ******* a ******** **** ******** ***** ** the *** ******* ** ***** ******** ultra ****-**** ****** ** ****** ******** and ********** ** ** ******* ** the ***. ***** **'* **** ** spend *** ******** ******* **** ********* that ****** *** ********** ** ******* and ****** - *** ********** **** allowed **** ** ******* ** *** first *****.
**** * ** **** ***** ** zero **** ** *** *** ** non ************* ** ******* **** ***** we **** ***** ** **** ********?
******* * ********* ********* *** ******* accommodation.
**** ****** *** ** ** ********** accommodations.
********? **'* * ****. ********** ************** cannot ** ****** ** *** *.*. Disagree *** *** ****.
***** **** ********* *** ******* ********** are ********* ** *** ************ ** United ****** ** ******* **** (***. 1992), ***** *** ** *** ***** Rights *** ** ****, *** ***** Amendment, *** **** ******** ****** ** the ***** *********, *** ****** *********, The ********** *********, *** ***** ********** Clause ** *** ********** *********, *** most **** *********** ***** ***** *** state.
** *** ****'* *** **** ******** on ****** ** ********* *** ********* accommodations, *** ****'* *** **** ******.
********... ***. ******* **** ** **** regret. *** **** **** **** *** is ** **** **** ******** **** is ********* ****.
*** **** *** **** ** **** for *** ** **********. * ************ mentioned *********** *** ************** ******* ** religious *** ******* **********.
***** *** ********* **, *** **** of *** *,*** ******** ********* ** medical **********?
***** **** ** *** * **** a **** **** *************. ** ******, they ***** ****** ** *** ***** labor *****? *****? **** ***….******?
******* ***** ******* *** ********' ********* exemption ****** **** *** *******
**** ***….******?
*** ****** ****'* **** ** ********. They ******** ** ****** **** ** comment.
******* ** *** **** * ****** not ** **** ** ***** **** states **** *** **** *** **********.
**** ******, ********* ****, ******* ************** Rights.
*************, *** ************ ** ****** ****** of ******* **** (***. ****), ***** VII ** *** ***** ****** *** of ****, *** ***** *********, *** Free ******** ****** ** *** ***** Amendment, *** ****** *********, *** ********** Amendment, *** ***** ********** ****** ** the ********** ********* **** *** ******* on *** *, ****. ***'* **** it *****'* **** **** ***.
** ***** ** ****...
** *** ******* ** **** *** useless...
...***'* *** ***** **** **** **** or *** ******* ** ** ***.
** ***** ** ****...
**'* ********* *** ****, **'* ***-****.
*** ******* *** **** ********** ******. Counting ********** ** * ***** ***** for *** ******* *** ****** *** data. *** *** *** **** ******** the ******* **** ******* ***** ***** the "********" *******.
*** ******* ******* *** ****** ** well. ***** *** ** ***** **** tell *** ********** ** *** **** COVID-19. ***** *** **** ***** ** Coronavirus, *** **** *** *** ******* the ****. **** **** *** **** shown ** ***** ******* ************ *** were ***** ******* ********. ******* *** been ******** ***** *** *********.
******* ***** *******. **'* ******. ** you're **** **** ****. ** ***'** really ****, ** ** *** ********.
*********’*? ******? *** ***** ******* ** sending *** ****** ****** **** **** and ****** *********, **** ***** ** getting ***** ********* **** ************?
**’** ******* ******* **** ******* ** the **** ** ************.
** ***** ** **** *** ****** of ****** ***** ** **** ******* a ******* - ********** ** *** requests *** * '********** *************' - is ***** ** * **** ****.
***** **** ********* *** ******* ********** are ********* ** *** ************ ** United ****** ** ******* **** (***. 1992), ***** *** ** *** ***** Rights *** ** ****, *** ***** Amendment, *** **** ******** ****** ** the ***** *********, *** ****** *********, The ********** *********, *** ***** ********** Clause ** *** ********** *********, *** most **** *********** ***** ***** *** state.
"**'** ******* ** ** **** ******* else" ***'* ****** *********** ********* ** any ** ***** ******.
** ****** ***** *** ***** *******.
*** ********** ****** ** ****** ** sacrosanct.
"**'** ******* ** ** **** ******* else" ***'* ****** *********** ********* ** any ** ***** ******.
** *** *.*., ** ******* ** if *** **** *** *** *** company ** ****** ** *********.** *** be **** ****** *** ****** ******* or ***** *** *** ********. *** Axis *********, **** ***** *** **** of *********** ************, ****** **** *** a ********* ** ******* ********* ****** have *** *** ******* ** ****** immediately. **** ****** ** *****, *** company ** ******** ** *** ** engage ** ****** ************* ***** *** employees' **************.
*** ************** ****** ** ********** *** should *** *** *********** ***** ** the ********. ** *** ******** *** prove **** **** ************* **** *********** cost, **** ************* *** ** ******. But ****** *****'* **** ******* **** to *** ********.
**** **** ** *** ******* ** that ************** *** ** ** ****** as *********** *' ****** ********** *** wearing * **** ** *** ******, during ******** ********, ***. **** ********* already *********** ***** *****, ** ***** are **** ************** **** **** ** no **** ** *** ********. ***** requests ****** ** ****** ******* ***** consequences.
* *** ** ******* ** ******, engaged ** *** ************* ************ (******** by ***), *** ******** ****** **********, masking, *** ***************** ** ** **************. These ************** *** *** ************.
** ******** *** ** *******. **** had ** ****** ***** ***** *** and ***** ********* ************* ****.
*** **** *********, **** ***** *** talk ** *********** ************, ****** **** had * ********* ** ******* ********* should **** *** *** ******* ** notice ***********.
*****.
** *********** *** **** *** ****** of******** ***** ** **** - ***** on *** **** ****** ***** ** people *** **** **************** *********** **** ******* ***** ******* ** be.
** *** ** ******* ******** ******* that ******** *** ** ********* ************* for *** *****, **** **** * myriad ** ***** ****** **** **** can ***** ** ** ***** ******** disqualifiers **** ****'* ******* ********* - without **** ********** ******** ***** ********.
* ** **** ******* *** ************ of ******** *** ** ***** ****** protections - *** **** **** ** not *****.
* **** * *** **** ******* for *** ********* ********* *** *** after **** ***** ******* *** ****** to *********. *** *** ******. *’* have ** *** *** *** ****** why ** *** ****** ***** **’* been * ****** ***…
* **** * *** **** ******* for *** ********* ********* *** *** after **** ***** ******* *** ****** to *********
*** ***** ******* **, *** ***'********* * ********* *********. *** ****** put **** ******** ** ******. ** exemption ** ********. ******* *** ****** "approve" **** ********* ******* **'* * personal ******. ** *****'* **** **** to ** ********* ** ******. ** just *** ** ** * ******** held *********, *****, ** ******* ******.
*** **** **** ** *** ******* accommodations. *** ************* ********** ****** ** denied. ** ** ******** ** ***, enforced ** *** ****.
**** ** *** ********** *** ***** process ** * ********* ** ******* exemption, ****'* *** **** **** ******. They ****** **** *** ********'* **** when *** **** **, *** ******** has **** ********** **** *** ********.
** * *********, *** ****** ** important. ** *** *** ************ *** a ***, **** ****** ******* ***** your ******* ******* *** ** ********.
*** **** ******* **** ****** ** exemption ***** *** *** *** *****. At **** ***** , ** *** are ****** **********, **’* * ********* of ***** ***.
** **** ******, ***** *** *********** with ****** ********* **** ** *** employer ******** ** ***, **** ** the **** ** *** ******* (****** of *********).
*** ****** ********** *** *** **** legal ****** **** ******** ********** ******* in **** ******?
*** ****** ********** *** *** **** legal ****** **** ******** ********** ******* in **** ******?
*** ****** *** ***** ********** ** me ** *** ** *** *** Constitutional ********* ** *** ****** ******. But ****...
** ******* ****** **** ***** ** anything, **'* **** ******** *** * "Top ************** ********" ** ***** ****.
*** ****** ********** *** ******** ******* advice **** ***** **** ***** ** the ****** ********?
*** *********** ****** **** ******* ******* immunity ** ****** ** *******. ***** me ****** *** **** *** ******* even *** ******.
*** *********** ****** **** ******* ******* immunity ** ****** ** *******
****** ** **** ***** ** *** 2022 ****** ******** **********. **'******** ******* ******* * **** *** T **** ********.
****:"***** ***** *** ****** ***** ** are ***** ** ******* *****-**?"
Bill *****:"Sadly, the virus itself particularly the variant called Omicron is a type of vaccine, that is it creates both B cell and T cell immunity and it’s done a better job of getting out to the world population than we have with vaccines."
******** **** *** ***** ** ***** properly (* ****'* ***** *** ****), the **** **** *** ***** ** creating **** ***** ** ******* ******** is *** **** **** ***** ** sad ***** (**'* * ************* *********), but ****** *** **** **** **'* done * ****** *** ** ******* out ** *** ***** ********** **** vaccines ****.
*** ******* ** * ***** ** build ******** **** ******* *****-** ******, and *** ***** *** ***, *** more **** **** **. *** *** not ******* **** *****-** (** ***** that *** ******* ******* ************) **** cause ******* ******* *** *** ************ because ** **** ******** *********, *** statistically, **** ***** **** *** ***** age ***** ***** ** *** **** I've ****.
*** ******* ****** ** ******.
** **** ** ****** *********** ** have ************ ** *** ************ **** COVID ******** **** ** ***** **** they ** *** ******* ********* *** increased *** **** ** *********** ** 133X.
*** *** ********, *** ** *****’* change *** *****. **** ******* **** study ** ****, *** ************* ****-******** medical *******.
** **** ** *********, *** ***'* take ** *** ** ***** **** didn’t ***********.******:*********** ***** ******** ***** ****-***** *****-** Vaccination ** *** ** **** ******** 2020 ** ****** **** | ********** | **** | **** ************://***.******************.***/****/******
*** ******* ** *** ******** ** now *** **** ******** ** **, moving *******, * ********** ******, *** a ****. *** ***** *** ***** who **** *** ******** * ******* or * ********* *******, *** ***** so ******* ******* **** *** *** unreasonable *********** **** *** ********, ** any ***** ****** ** *** **** of *******, ****** ** ******* ***** of * ******** ****. ******* ****** little ***** **** *** ***.
*** ******** *** **** ******** ** reduced *** ******** ** *** ********* of *** ****** ** ** ******* to ***** ******* ******** **** ********* which *** ******* ***** *** **** of ****** *************. **** **** **** and ******** ** ** ***** ********** in **** ******. *** ***** **** and *** ** * ******** ** a ******** **** (********* ****) **** or *** *** *** ***** **** is ******* ** *********** *** *** specifically ******* ** ******** ** ********* care. ** **** *** ******** ***, anything *** ********** *** **** ** create ** ******* ********** *** ******* response **** ******* *********** **** *******, but ***** (*** ****) ************* ****** the ****** ** ****** ******** *** worlds ******** **** ********** *** *********. This **** ******** ***** ********** ******* to ******** ** ******* **** **** for *** ********* ******** **** ******** in *** **** ** ******, *****, transplants *** ***** **** *********** **********.
***, ***, ***** *** ******** ** the ******* ******* *** ***** ****. Lets *** *** **** *** ******** and **** ** ****. *** ***** is ******* ******** **** **** *** statistical ********* **** ********* *** ******** effects ** *** ******* ******. **** your *** *** ***** ******** ********* else. **** ** ** ***** ******** conversation.
******* ** **** ** *********, *** employees ******* ***** ****** **** **** their ******** *** *** ******* ******** of **** ****** **** ** **** for ** ****. **** *** *** should *** ** *** ****** *** the *****, ** ******** * *****, present, *** ***** **** ** *** company's ***** (*********), *****, *** ********* resources ** ****, *** *** ******** who ****** ******* **** **** *** a ***** ** ******* **********, ***** customers, *** ***** ********* ********* ****** either ***** *** *** *** ****** benefits **** *** ******* ******** *** them, *** ***** *** ****** *********, and ** ******.
* **** *** ****** ****** *****. My ****** ****** *** ***** ********* is *** "** *** **** *** health *********" ****** - ********** *** some ** *** *** ***** *** have ***** ******* *** ** ******. After ***** **, *** ***** ********** being ** ***** * *** ****.
(*** *** ******, * ** *** work *** ****, *** ** ****** pissed ** **** *** **** ********* reasons **** ***** ******* *******) *** I *** ***** **** ***** **** on *** ******* ******* ******* ** capable ** ******* *** ******** ***** in ** **** ** *** ****. Its *** * *** ** *** bottom ** **** ******* ******** *** news.
* ************ *** "*****", *** **'* not * ***** ** ** ******** for.
******* ****, "***** ******** ************" **** calling ****** "******* ****** ****** *****..."
***'* **** **** * ****** *** try ** ***** **** ******-*****:
*. ** ***, *** ****** ** receive *** ********* ********** *****, ** prevented **** ********* ****. ** *** is ********** **** *** ***** ***** be ******. *, **********, ***'* **** if ****** ****** ** **** **** once * ****, ** **** ***** they **** ****. ***** ******.
*. **** *** ****** *** ********, simply ****** ** ***** ****** ** take ************ *****, **** **** ******* carry **** **** **** *** ******* itself. ************* ** ******* *************** *** never ****** **** ******** ** *********. If **** ** *** *********, *** much ******* **** ** **? ** is **** **** *** **** ********** carry **** ** ****** & ***** which ****** *** *** ** *** other ******** ************, ********. ***** ***** is ****, ***** *** ** ** choice.
*. **'** *** *** *** ****. The ****** ** ****** *******/***** ** different, ********* ** **** ********** *******. The **** ********** ****** *** ** one **** **** ***. *** **** vs ******* *********** **** ** ** individual ********, ** ** *** ****** been.
*. ************ ********: ***** ** ***** risk ************** **** ******* **** *** risk ** ****** *******/*****, **** *****, is ************* **** *** ****** **** low ***, (*** **'*). ** *** believe ** ** ********'* ***** ** mandate ****** *** ********* *********, ** a ********* ** **********, **** * strong ******** ***** ** **** *** mandating ****** & ****** & *** standards. **** * ****** ***** **** far **** ****** **** **** **** injections *** ******* *** ****** ** adverse *********/******. ** ****, *** **** effects ** ******** ***'* ******, **** and ******* *** *** ******** *** lead ** ******* ********* *** ******** quality ** ****.
**** ** ********* ********** ****** *** would *** ****** ** ******** *** maintaining ***** *** ***** **? **** if ********* ******* ** ****** ****-****, overweight ******? *** ***** ***** **** be? *** ******, ****** *** ********* would **** **?
**** ** ****** *****: *** **** way *** ** ** *** *******, without *********, "******* ****** ****** *****..." at *** ******* ** *** **** to ** **** **** *** ******* of *** *****. *** ** *** and *'** ** **. ** **** as ******* ** ** *** *** power ** **** **** *** *****'* personal ********* *******, **** ** *** all **** ** *******. **** ** the ****** ** *** ********** *********. They ******* ** **** **** *****, allowing ** ** ***** ** **** unites, ****** **** ******* **. ***'* restore *** ****-****** ********** ** ******* privacy *** ********** ********. **** *** divisive ************* *** ****** **** *** need ** **** **** ******* ****. Peace.
**** ****: ** **'* *** ** to ***** **** *********' ******* ******* and ******* ****** *** ********* *******, as ********** ** **********, **** *** covid **** ***** **** ** **** the *********.
**** *** *** ** ** *** best ***** ** *** ******* *'** read ***. ** ******* ******** ******* of ****. *** ****** **.
********* **** ********* ** #* "** is **** **** *** **** ********** carry **** ** ****** & ***** which ****** *** *** ** *** other ******** ************, ********."
** *** **** * ****** ** site **** ********* ** ****?
* ******* **** ****** ***** ** reference ***** **** *** ****** ** support **** *********:*** ***** ******** ****** ******* ** mRNA ******** **** ********* ********
*** ******* *** ******* ******* *** Prevention (***) *** *** *.*. **** and **** ************** (***), ****** *** latest ******* ** ******** **:
******* ******* ******: *,***,***
******* ******* ****************: ***,***
******* ******** ******: **,***
******* ******* ****** ******: ***,***
******* ******* ****** ****: ***, ***
******* ******* **** *****: **,***
******* ******* ***********: *,***
******* ******* ************: *,***
******* ******* ***** *******: **,***
******* ******* ***********/************: **.***
******* ******* *********** ********: **,***
******* ******* ****************: *,***
******* ******* ********: **,***
*** ***** *** **** *** ******** events.
***:***: ******** ******* ****** ******** ***** COVID-19 *********** ******* ***. **, ****
**** **** *** ******* ***** ** COVID-19 ******** **** ************ ** *** United ****** **** ******** **, ****, through ******** **, ****. ****** **** time, ***** ******** **,*** *********** ******* of ***** (*.****%) ***** ****** *** received * *****-**
*************** ****** ********...
***************** ********* *** **** * ***** for *** **** *** *****.
*** ***** ******** ******* ***********, *** causative **** ****-***********.
**** ***** *** **** *** ** in ***********:
***** ******* *** *****-** ******** ******* 01/14/2022 – ***** ********
* *** ******* **** * *** that *****... *** *** *** ** to *** ***** ***** ******** *** generate *** **** *****. ***** ** is **** **** ** **** *** prove ********* - *** **** ***** be **** *** *** ** *** other ********. ********* ** ***** ****. And ** ****** ***** *** ************ injuries - **** **** ***** **** it **** *** ********. *** ******* at **** ***** *** ****** ** least ********* **** ** ***** ********** liberty ** ****** ******* ********* *****.
*** ** **#** ***** ******* *** - ** **** ** **** ***** insurance *****, ****** ** *** *** to ** ********** ** *** *********. These *** ********* *******. ***** ** the ********** **** ** **** ** diabetes **** **** *** *** - and **** ** ******* * ****-***** disease.
********* **** ********* ** #* "** is **** **** *** **** ********** carry **** ** ****** & ***** which ****** *** *** ** *** other ******** ************, ********."
********** *** ******** ***** **** ***** is **** ***.
****'* ****. ** *** **** ******** when *** ***'* **** ******** ******* for ** ************ ******* ******* *** government ********** ***** ***** ******* ** data ******* ** *** ****** **** that ****, **** **** *** ****** would *** **** **** ************ *******?
*** *.*.*. ***’* ********** ***** ******** of *** ***** **** ** ******** - *** *** **** *****
*** ********* **** ** **** ** supporting **** ********** ************** ***** * vaccine **** ** ****** **** *** effective. ** ** *******, *****'* ** point ******* ******* ***** **** ****** that **** ********** **** *** **** pundits ******** ********.
*** ********* **** ** **** ** supporting **** ********** ************** ***** * vaccine **** ** ****** **** *** effective. ** ** *******, *****'* ** point ******* ******* ***** **** ****** that **** ********** **** *** **** pundits ******** ********.
*****, ***, *** *** ******* *********, cannot *** **** *** ********* **** experimental ******** **** **** ****** ****. Not ** *******, ******* *** ********* in ****** **** **** *** **** the ***** *** **********.
******, * ***'* ***** ** ****** Fox ****. * ***'* **** * talking **** ********** *** ******* ** explain ******** ** **. * **** details ** *********** *********, ******, *** audio ** ********* *** *********. * get *** ******** ** ** *********** from ******* *** ***** .*** *******, hearings, **********, **** ********* *** ********* via *** *** *** ****** *** CSPAN *** ******* **********.
* ******** ** ******* * **** to * ************* ****-******* ********* ********* on *** *** *** ******* **** because * ******* ***'** ****-******* *** you *****, ******* *** *****, ********* the ***** ** "*** ****!". ** assumption *** ***% *******.
* **** *** **** **** **** here. ******* ** ******** *** *****, the **** ******* ** **** ******** is *********** ** "***** ***********" *** "racism".
**** ***********.
*** ******* ******** ** **** * partisan ** *** *** ****** **** her *** ******, ***** ** **********.
*** **** *** *** ***** ***** the **** ** **** ** ***********, but *****, **** ** **** **** not ******* * ********* ** ******** outcomes - *** ** **** **** into ********** ***********.
********* *** *** ********* ** *'** stop *****. **** ***, *** **** health.
- **** **** * **** ****** sense, ******** ** *** ********** ****** and **********.
*** *****, **** ** **** **** not ******* * ********* ** ******** outcomes
*** **** ** ******* ******* ******** outcomes.
******* "**********"? ***.
****'* * **** ****** **** *** has *** *** ** ********* ** support ***/*** ********.
**** ********** ************** ***** * ******* that ** ****** **** *** *********
**** **** ***** **** **'* "****** to ** **** *** *********" ** you?
**** *** ****: "************ ******** ****** ********** ******* ** multiple ***************** *** *******...
***** ** *** *** **** ***********?
************ ********** **** **** ******** *********** medical ************ *** *********** **** *** vaccines *** **** *** *********. * never **** **** **** ******* ****. The *********** **** ** ********* ** vaccination *** ******** ********, ********* ********* of ***********, ******** *******, ***. ****** be ******* ** ******.
*** ******* **** *** "************ ****" showing ** ** "**** *** *********" is **** ** ******* ** **** accurate **** *** **** ** *** see **** *** ******. ** ****** that *** *****-******* ****** ******** ******** wants ** **** ******** *********. ** assume **** *** ***** ****** ******* most ******* ******** - *** ** course ** **** ** **** ******* a ******** ** ****. *** **** you **** ******** ******* **** **** coming ***:*****://*******.***/********,
** *** **** *** ******* *** scientifically ****** ** ** **** **** little **** ** ** ******** ********* if *** ******* **** "********* = scientific *****". *** ** ****** **** would **** **** **** ** ****** still ** ***** ************ *** **********.
** **** **** **** ** **** the **** ****** ** ******* ******** - ** **** ***'* **** *** and ***** ** ** **** ********* of ******** ******* ********* ****** ************* and *** *****.
* ***** ***** **** *** ********** is *** ***** ********* ** ******** on * ******** ** **** **** impacts **** ** ****** **** *** general ****** **** ********* **** ****** them ** ***** *** ***/** ** deaths ****. *** ****** **** ** it ******.
* **** ******* *** *********** ******** all *** **** **** ********* ** them ** *** ******** *** ***** manufacturers **** ******, *** ********* ******* on * *** ***.......
................** ****.........
*'* *** * **** ** ** arm ****** *'* *** ** * plane **** *** *** ***** ******, so *** ** ***** * ****** standard?
*'* *** * **** ** ** arm ****** *'* *** ** * plane **** *** *** ***** ******, so *** ** ***** * ****** standard?
*** **** ********** *** *.*. ********** isn't ****** ** ***** ****** ** fly.
* ******** ** *** ************ *** nothing ** ** **** ** **********'* constitutional ****** *** *********, *****, ** ethical ******* ******* ** ****** ******* procedures.
* ***** ***** **** *** ********** is *** ***** ********* ** ******** on * ******** ** ****
**'* **** * ****** ***** ***** this ****. *********** **** *** **** published. *** *** ** **** * convenient *** ** ******** *** *****.
**** ***** ** **** *****. ********** a **** ****** ** ***** *** a *** *** **** ** ** dissertation. *** ** *** ** **** way.
*** ******** ****** *** *******. **** are ******* ***********, *************, *************.....** ******** to ********** ***** ***** ******* ** the *****, *** **** ******* ** almost ***** ****** ** ***** *****, (comparatively) **** *** ******* *** **** can *** ** ***** ************ ******* because **** *** *******.
*** ******** ****** ****** * ****. They **** **** ** **** **** science ** ****** ** **** ** it ***, *** **** *** ******** to **** ****** ******** *** **** triaged ** **** ** ******** *** that ***** ************** *** ***** ******* against ***** ******. ******* ** ********* science *** *** ********* ****** **** they **** ** ** ********** ***** period ** ****, **** ********* **, and **** ******** ** ******, ******, demand, *** **** ******** ** ** so **** ********** ** ************* *** the ****** ***** ******* **** ** their ****** ********. **** **** **** to **** **** ** ******** **** is ********** ******** **** ** *** long ***. "* **** ****, * dont ****, * **** ****" ** the ****** ***, "* **** ***** be **** ** ****** ** ** anything", **** **** ** *** ***** thing ** **.
*** ***** ** *** ***** ***********, any ****** *** *** **** *********** a * **** *** ****** ****** brat *** ****** ***** *** *** spinich, **** **** *** **** *** him, ***** ******* **** ** **** that ****** ****** ****.
*** ******* ******** ****** **** ***** as ** *******. ** ******* **** not ****** ** *** ***, *** person ******** **** ** **. **** not ***** *** *** ******* **** standing **** ** **. * *** eat ** ****** ***** ** ***** of ***, *** **** ****** *** health **** *** ** ******** ** any *** ** ** *** ******** health ********. ***** *** ***** *** viral ********* ****, *** ******** *** to **** **** ** **** ********* and *** ****** ** ***** *** behave, ** ******* ********, ** ******** with ***** ****** ****** * ******** is *** "* ********* ******". *** not **** * ********* ******. **** it ** ** ******** ************ ** innocent **********, ***** ** ********* ***** Axis, *** *****, ***** *** ******* Authorities **** *** ***** ** *********. I ***** **** ** *** ** spinich ******. **** ****** ** **** me *** **** *** **** ** gonna ***** ** ** ***. *** dont **** ** **** *** *******. That ***** **** **** **** **** so ****, *** **** *********** ***** to *** **. *** ********** ******* the ******* *** *** ***** ** that ***** ** **** *** **** day ***** ****** **** ******** ****** others ** ***** *** ** *****, no *** *** ***.
*** **** ** *** *** **** spinich.
*** ** ********** *** ********** ******* a ****** *** *** ******* **********, right?
*** ********** ******* *** ******* *** the ***** ** **** ***** ** work *** **** *** ***** ****** your ******** ****** ****** ** ***** way
*** **** ****** **** ****** *****. Both ********** *** ************ *** ****** the *****.
** ******* **** *** ****** ** any ***, *** ****** ******** **** to **.
**** *** **** *** ******* * lot ** ******* ******.
** *** **** ** * ******* with ******* **** **** *** ** the ******'* *** ******* **** **** obesity **** ****** ******.
...*** * ***** **** *** ******* is *** ******** ******* **** ***** will ****** **** ******* **** **********....
***'* ***** ** ** ***...
***'* ***** ** ** ** *********** to *** *********** ******** ** ** the *****.
...*** * ******** **** **** ********** of ********* ******* * ****. *** I'm **** **** **** *** **** that *** *** * ***** ******* that **** ********** **** ** * virus *** *** ********* ** ** "cured" **.
***** ********** ************* ******* *** **** of * ****** ***** ** * critical **** **** **** **** ******** the *****. *** ******* ********** ******* the *** ***** ** *** ******** argument ** **** **** *** ******* in * ****** ** ******* * vaccinated ****** ****** ** ************ ****** can ****** *** *****. **** **** do *** *** *** *** ******* point ** *** ****** *** *** not **** *** ******* ******* ** trying ** *** ****** ******,
*** ****** ****** ** ******** ****** how ******** ******* *** **** * huge ********** ** ********** ******** ********** after************ *****, ********** ** ***. ** that *****, ******** **** ***** *** everyone ** ********* *****. **. ***** ya **. *****? *** ** **** scenario, ***** *** *** ********** *** taking ******** *** ** ******** ******** medical ********* *** ***** *** *** not *** *********** *** *******, *** forcing ***** *** ***** ******* ******** care ******** **** * ********** ***** that ******* ********* *****. *** ***, let *** ********** ******* ***. ** least **** ****** ****** ** ******.
***** *** *** ********** *** ****** pressure *** ** ******** ******** ******* resources *** ***** *** *** *** are *********** *** *******
****'* *** **** ** ***. ***'** completely ******* ******* ******** ** ** anyone *** ******** ****'* *** ********** require ******** ****.
***** ***** *****.
*** **** **** ********* ******* ******* and ******* ******** ** ****** ***** your ********** **** - ****** *** not ***** ******* ** ***** ***** taken ** ** ****** *** *** not *** *** *******.
*** **** ** ****** ** **** of ***** *** **** ******* ** health **** ******* ** *** ******** of ******* ******** *** ***** ** health **** **** *** ******** ****. I ******* * ****** ****** *** of **** ** ******** ***** ***** told ** **** ****** *** ********. The ******* *** *******. ******** * million ******* ***** ** *** ****. I ******* ******'* ***** ** *** what **** ****. * *** *** his ******. *** ********** *** *** his ******.
* ** *** ***** ** ***** overweight ****** **** ****** * ** not. ******** *** ********/******/******* ***** - I've *** ** ***.
*'** ** ** - *** ** you.
...***** **** *** ** ******* **...***** is *** *****'* ********
*** ****-***-* ************ *** ******** ***** are * ****** ** *******.
****'** *** **** ******** ** ******* in ***** ******** *** *** ******* on ******* **** ******* ****.
***** *******.
****, *********** ****** **** ***** ** *** debate **** ** ******...
******* **** **** ** ***** ********** and **** *** ****** *** *****.
**'** ***** *** ** **** ********!
* ***** **** ****** ****** ****** - **** (******* ** * *******) free **** ***** ***** ************.
**** *********, ***** *** ***** *** of *** *********, **** * ****** relative ** *** ********, ********** ** some ** *** **** *** **** the ** ******* **********. **'* ************* to ** **** **** ** ******* Axis *** ** * ******** *******. Employees ********** *** ** **** **** new ******* ***** *** **** ** doing ********. **** ** *** ***** employee ****** - ** ********* ** read ***** ********* ******* ***** *** results. *** **** *** **** ** the ********* **** ** ****** *** not ******** **** ***** ****** ***** political ********? **'* * **** ***.
** ******** ** **** ******* ** is * ******** ***** ** * major ******* ** *** ******** ** cover *** **** ****** ** ******* unvaccinated ********* **** *** ******** ********* is ********.
* ***'* **** *** ***** *********** devolve *** **'* ** ******** ********** of *** ***** ** ******** ****** the ******** **** ***** *** ********.
**** ********* **** ** *******, ** can't **** ***** ****** ** ******** to ***** ********** *** **** ****** is ** ******** ** **** ** our ***********.
************ *** **** *** ******** *** many *********, ********** ***** ************* ******* the *.*., **** ********* ******** **** in ***** ** ********* **** **** was ******. * **** **** ***** were ***** ****** ********* **** ********** unvaccinated **** ********* ** **** ** coming **** *******. *** **** ** the ********* *** *** **** ****** in ********** ** ***** *********? *** this ******* *** **** ** ******** a ****** ***** ******* ****. **** is *** ** ********* ******* ** all *** *************. ** **** *****, there *** **** **** ******** **** don't ******** **. **** *** *** interest ** ******* ** ** *** of *** ******* (*** *** **** one) **** **** ** **** *******, the ******* *** **** ******* *** clearly ******* ****** ** ****** ****. As * **** ** ** ******* comment, **** ** *** *** ******** we ****** **** **** *** **** it ****** ** *** ******** ******. Companies *** **** *** ***** **** learned ** ** ********** **** ******/******* workers ** ****** ************ ** **** as ******* ******. ** ****** ******** and *********** *** ** ********** ** a ***** ** *****. ******. **********, Options. **** ** *** * ***** for ******** ******* ****** ** ** impacting **********, ***********, ** ***** ******** practices (***** ** *** ******* *** can ****** ** ****** ***** **********). Business *******, **********, *** *** ********* issues *** ***** *** ****.
************ *** **** *** ******** *** many *********, ********** ***** ************* ******* the *.*., **** ********* ******** **** in ***** ** ********* **** **** was ******.
** ******* ***** ** ***** ************* and **** **** *** **** ******. To ** *****, ** *** *** claiming **** ** "******" *** ** the ******* ********* ** *****, **** what ** **** ****, **** ** the **** *** ***** ****. ** Hikvision ** ******** (** ***** ***** manufacturers) *** ****, ** ***** ********* cover **** ***.
**'* * **** **** * ****** of **** ********* **** **** **** this (*** **** *** ***** *** their ************), ** **** ** *** more **** "******** *******".
**** *** *** ******** ** ******* it ** *** ** *** ******* (not *** **** ***) **** **** we ****...
******* ************. ***'* **** *** ****/***** work?
** ******** ** **** ******* ** is * ******** ***** ** * major ******* ** *** ******** ** cover *** **** ****** ** ******* unvaccinated ********* **** *** ******** ********* is ********.
* ** *** **** *** ******* dodged ****, *** **** **** ******** all ********* ** ** ********** ** else... **** **** ******** ***** ******** to **** ***** ** *********** ** attend ***** ***** ** **. ** testing ******.
**** ** *** “********” *** ******** employees ** **** ***** ********?
** **** *** **** **** **** a ******** ********, *.*., ** ** by * ** *** *** *****.
** *********** **** ** **** **** is ********* ***** *** ***** ** firing ****** **** **** *** *********, as **** ****** ** *** ** their ******, ** ****** *** ****** to ****** ** ******.
**** ** * ********* *******, *** they *** *** *** **** ********, in *** ********, ** ******** * policy ** *********** "************" *********. * suspect **** *** **** ** ******** termination ********** *** *** ** *** only **** **** ** ********** (** should ** **********) ** ****.
********* *** ****** ********* **** ********* unwanted ******* *************, ** * ********* of **********, ***, ******, ******** ********* for *** ********** ******/*****, ******** ** their *********, *** ******* ** ****.
************** ********* **** ********* ******** **********, by ****** ** *** ******, **** liability *** ******** *** ****** ****** by ***** **** **** ********. *** OSHA *******, (****** **** ** ******), has **** *********, ******* *********, **** Axis, ** ** *** ***** **** by *********** ******** *** ******* ** their *** *********. *** ****** *** drug *********, ********* *** *** ******** from ********* *** ******** ********* ** their *********, ********* **** ** ********-******** treatment. **** ******** *** ****** ********* compensable, ********** ****** *** *********’ ******** consent. ***** ***** ********, *** ****** of ***********, ** *** ******** *******.
*********, ******* ************ ****, **** * number ** ***** *******, ***** **** the ***'* ***** **** *** *** DMED ****, ************ ******* **** *******-******* injuries *** ****, ***** ******, *** not ********. *** **** ***** **** released ****** ********** ** *** **** term ******, ** ** **** ** years ****** **** **** ******* **** be *****. ** ***** **** ** now *******: *** **** **** ****** are ********, *****, ***** ** ** as ****-*********** *********. *** *********, **** Axis, ***, ************* ** ***********, ********* their *********' *************, ** ********.
******. *************, **** ******** ***** *** much ***** *** **** ****.
"**** ** ********* ***** *** ***** of ****** ****** **** ****"
*** **** ***** ** ** ****. Let's **** ******* * ***** ***** for *** ***** **:
* ******** ***'* ******* ******** ** transmitting *** ******* (**** ***** ** end *** '*******' ******** ***** *****)
* ******* ******** ** ****** **** vax ********/ *** ****'* *** ***** considered
* *** ******** *** *** ****** only, *** ********* ****** ** **** liable.
* ** ******* ***** **** *** been ** *** ********* ** *** CDC = ** ******** *******
* ** ************* ** ************, ***** treatments (*** *****, ******* ********)
**** *** ** **** ****; *** does * ******* ******* *******? ** doesn't. (*** ***'* ****** **** *** ******** bed ******). * **** ****. * **** and **** **** ** *** ********** at ****. **** ** **** *******. There ** ** ******* ****** *** this. *** ****. **** ************.
***, ***'* *** *'* ** ***** old, *******, ******* + * ****, I *** *** '**** *** ********* and *** ******** ******, * ***'* want *** ***. *** **** ** coercing ** ** ********** *********** ** job, ****** ** ** ******, ********* my **********, ***.. ****** * *** it.
***'* *** * *** *** *** and ***. ** **** ***'* *** the ***, ** *** ******.. ***'* left? **** - *** ************ **** coerced *** ******. ******** *****'* ******** documentation (*********** / ****** ** **), it's ****** **** **** **** ** in *** ***** ******* *** *** the *****.
* **** ****. * **** *** like **** ** *** ********** ** Axis. **** ** **** *******. ***** is ** ******* ****** *** ****. Bad ****. **** ************.
********* ****:
*** ******** ****** *** *******. **** are ******* ***********, *************, *************.....** ******** to ********** ***** ***** ******* ** the *****, *** **** ******* ** almost ***** ****** ** ***** *****, (comparatively) **** *** ******* *** **** can *** ** ***** ************ ******* because **** *** *******.
* ***% ***** **** **** ********* are *******-- ***** **** ***** ***** feet ******* **** ***'* ***** **** them ** ** ****** "***** ***" end ** ******** ******** ** ****** media **** **** ***'* ****** ***** arguments **** *****. *'* **** ** see **** ********* ***** **. ***** are ** **********. ********* *** ****, consequences ******. *** ** ***, *'** do **.
**#** **** **** ***'* *** **** company ****** ****- *** ****'* ****. I'd ** *** ** ***** ********* ends ** **** * ***** ******. Axis's ****** ***** ** ******.
*** **** *** * *******..
***, ***'* *** *'* ** ***** old, *******, ******* + * ****, I *** *** '**** *** ********* and *** ******** ******, * ***'* want *** ***. *** **** ** coercing ** ** ********** *********** ** job, ****** ** ** ******, ********* my **********, ***.. ****** * *** it.
******** ***?........******** ** *** *** *****.
*** ************ ** *** ******** **** changed. ***** ******** *** * ******--**** can **** *** ************ *** **** in ***** ********, ** ****** *** to **** **** *** ** ******* from ***** ********.
** ***** ** ******* ** *** marketplace ** ** *** ******** *** salespeople ** **** **** ************ ** them **** **: *********** ** ****** 3 ***** ** ***** *****, ***** driving ******, ** ********, ***....
** ********* ***** ******* **** **********, onto ******** *****, *** ********* ** modes ** ********* **** *** ******* vaccination, **** *** ** **** ***** to ******* ** ** **** ***** who *** ******* ** ******* *** Axis ********?
**** ***** ****** ****** *** * choice.
*** - ** *** *** ******** getting ***** ******* *** ********* * felony *** ******* ***** *** *** repeatedly ********* * ******** *** ********* don't **** ** *** **** *****? I ***'* **** **** ***** *** could ***** **** **** ***...
* ***** ***** ** * ***** integrator **** *** ********* **** ****** because ** **** ******.
**** ****** ** **** *******? *** Difference. ** **** **** ********** **** Products ******* ** ****, **** ***** actually **** ********* *** ** ******** would **......
**. *** **** **** **********.. ***** next?
** ******* ***, *.*. ******** ***** Mark *. ************* * *********** *** *** ** ******** *** Pfizer ******* **** *** *** **** 75 *****.
*** *********, ******** ** ***** ***, 2022, ******** ** ******** ******, “**** OF ******* ****** ** ******* ********,” which ******,*** ********* ******* *************** ***********.
* **** **** ** ********* *** be *********.
* *****'* ***** **** ***** ** his ********* **** ******.
***** *** **** ******** **** ** you, * **** **** ***** "*******" situation **********. ************ *** ** *** evidence **** **** * ***** ** the **** ** ***** ******** ** Dunning-Kruger.
**'* ********** **** *** **** ***** ones *** **** ***** *** ****** the **** **** *** **** ********** on ***** **** ** **** ** LinkedIn *********** **** **** **** ** get ********** ** **** * ****. Furthermore, ********* ** **** ****** ** what *** ** ** ******** *** online. **** *** *** *** ***** is **** ************ **** *** ** may *** **** *** ** *** butt **** *********** ** **** **** interview ***** **. *** **** **** Mr. ******** ******* ****** **** ** his ********, *** * **** ***** move *** ***** ******.
** **** ** **** ********* *** mindful ** *** ******** *** ******** access ******** ** ***** ** ******* as **** ** **** ******** *** with *** **** ** ******* ********. While ** *** "****" ** ****** the ******* *** ********** ** *** company, ***** *** ****** ** ***** companies *** *** ****** **** ** to.
***** ******, *****… ******?